## Abstract (+)‐__N__‐[^11^C]‐Benzyl‐__N__‐normetazocine (1__S__,5__S__,9__S__‐(+)‐__cis__‐2‐[^11^C]‐benzyl‐2′‐hydroxy‐5,9‐dimethyl‐6,7‐benzomorphan), a potent and selective ligand for the σ receptor, was prepared by N‐benzylation of (+)‐__cis__‐__N__‐normetazocine with [α‐^11^C]‐benzyl iodide in e
Synthesis of the anxiolytic agent [14C] 6-hydroxy-buspirone for use in a human ADME study
✍ Scribed by Samuel J. Bonacorsi Jr; Richard C. Burrell; George M. Luke; Jeffrey S. DePue; J. Kent Rinehart; Balu Balasubramanian; Lisa J. Christopher; Ramaswamy A. Iyer
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 124 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A reliable synthesis of ^14^C labeled 6‐hydroxy‐buspirone is described. The molecule belongs to a unique class of compounds with the potential for anxiolytic activity. A radiolabeled analog was prepared to support the development of 6‐hydroxy‐buspirone. Specifically, a labeled variant was designed to meet the requirements of a human adsorption‐distribution‐metabolism‐elimination (ADME) study. Multiple ^14^C labels were needed to fully track the potential metabolic transformation of the molecule. Labeled 6‐hydroxy‐buspirone was prepared by oxidation of separately labeled versions of [^14^C]buspirone. The final product was isolated in reasonable yield with a radiochemical purity of 99.8%. Copyright © 2007 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES